| Item |
Type |
Meaning |
| Active Ingredient |
1: Draft |
A chemical component of a drug product that supplies pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment or prevention of disease, or to affect the function of the human body. Defined based on Drug Product. |
| Additional Address Description |
0: In Development |
Supplementary details provided alongside the address for further context or clarification. Additional Address Description includes precise customer information to ensure that mail or packages are delivered to the proper address. |
| Address |
0: In Development |
Information used to identify a physical location. |
| Address Line 2 |
0: In Development |
A field for additional information to aid in the identification of an address. Address Line 2 includes address unit designators, such as apartment, suite, room, or floor numbers. |
| Adverse Drug Reaction |
1: Draft |
An unintended response that occurs after exposure to a drug product. Examples of adverse reactions include anaphylactic shock, hives, and seizure. |
| Adverse Event |
1: Draft |
An event that is related to unintended effects on a patient. The unintended effects may require additional monitoring, treatment, hospitalization, or may result in death. Adverse events can be reported by healthcare providers, patients, caregivers or by medical product manufacturers. |
| Alias |
0: In Development |
Alternative names or labels that a concept or term may be known as in various contexts. |
| Allergy / Intolerance |
0: In Development |
An immunological hypersensitivity (allergy) or a non-immunological adverse reaction (intolerance) to a substance. Examples of allergies are reactions to bee venom, pollen, and tree nuts. Examples of intolerances are reactions to gluten and lactose. |
| Allied Health Professional |
1: Draft |
A regulated professional who is involved in an aspect of care for patients, such as diagnostic, therapeutic, and direct patient care services.
Examples includes physician assistant, midwifes, and Orthoptist.
Exclusions:
• General practitioners and family physicians
• Managers in health care
• Nurse practitioners
• Other practitioners of natural healing
• Other professional occupations in health diagnosing and treating
• Registered nurses and registered psychiatric nurses
• Specialists in clinical and laboratory medicine
• Specialists in surgery
• Traditional Chinese medicine practitioners and acupuncturists |
| Altitude |
0: In Development |
The absolute distance above sea level. |
| Appointment |
1: Draft |
A scheduled booking of an encounter among patient(s), providers(s), and/or related person(s) for a specific date and time. |
| Assessment |
0: In Development |
The evaluation of a health concern by which a provider assesses a patient's symptoms, medical history, clinical findings, and/or diagnostic test results to form a clinical judgement/professional opinion regarding a patient's health concern. |
| Attribute |
1: Draft |
A characteristic of an entity that provides more specific information to distinguish it from other entities. |
| Basis of Strength Substance |
0: In Development |
A code that designates the substance against which the strength quantity(s) of the product(s) are measured. There will be a basis of strength substance stated for each active ingredient substance present in a multi-ingredient clinical drug product. Examples include Coversyl: 4 mg of perindopril erbumine per tablet, and Dilantin: 50 mg of phenytoin sodium per capsule. |
| Birth |
0: In Development |
The act of a person being born. |
| Body Site |
1: Draft |
A specific anatomical region or structure on or within the human body. Body Site may include laterality. |
| Business Context Model |
0: In Development |
This defines the scope of the Pan-Canadian Health Data Content Framework. The Business Context Model defines the people, organizations, and systems that influence and inform the content, the collaborators, and those that govern and fund it. It also defines the consumers of the Framework and the methods by which they will use it. |
| Business Glossary |
1: Draft |
The Pan-Canadian Health Data Content Business Glossary provides terms, their definitions, and semantic relationships describing clinical and architecture concepts used across the Pan-Canadian Health Data Content Framework. The glossary establishes a standard vocabulary to support clear communication and common understanding of terms across Canadian health systems.
|
| Business Number |
0: In Development |
A unique, nine-digit number and the standard identifier for businesses and legal entities registered with the Government of Canada. |
| Business Rule |
0: In Development |
A specific statement that defines or constrains some aspects of business operation. These rules can cover governance, business processes, data management, and regulation compliance. |
| CA Core+ |
2: Proposed |
A set of FHIR profiles that enable common data exchange formats across domains, while also supporting domain-specific data exchange. The CACDI and CA Core+ work in tandem to facilitate interoperability and data exchange within the Canadian healthcare landscape. |
| Canadian Clinical Drug Data Set |
0: In Development |
The drug interchange terminology used in Canada to uniquely identify and accurately describe drugs and drug products (and some medical devices) in a standardized format with defining properties.
The Canadian Clinical Drug Data Set is freely used for digital health solutions and design applications. |
| Canadian Core Data for Interoperability |
2: Proposed |
A subset of the Pan-Canadian Health Data Content Framework that aims to define a standardized set of essential health data elements and associated value sets in the context of a common architecture to support interoperability and data exchange across the Canadian healthcare ecosystem. The development of CACDI will follow an iterative design process and will expand over time. The CACDI and CA Core+ work in tandem to facilitate interoperability and data exchange within the Canadian healthcare landscape. |
| Canadian Geographic Region |
1: Draft |
The grouping of provinces and territories established for the purpose of statistical reporting. The six geographical regions of Canada are:
Atlantic
Quebec
Ontario
Prairies
British Columbia
Territories The Geographic Region definition fails to capture the rural and remote aspects of Canada's geography in healthcare. |
| Canadian Postal Code |
1: Draft |
A six-character alphanumeric code defined and maintained by Canada Post Corporation for the purpose of sorting and delivering mail. Defined based on Forward Sortation Area (FSA) and Local Delivery Unit (LDU). The Postal Code is a six-character uniformly structured, alphanumeric code in the form “ANA NAN” where “A” is an alphabetic character and “N” is a numeric character. |
| Care Team |
0: In Development |
All individuals involved in the delivery of care and support for the patient over a period of time. These typically include the patient themselves, clinicians, and caregivers. The Care Team may be associated with a specific encounter with one patient, a group of patients, or an episode of care and share in decision making and accountability for the patient. The specific composition of teams depends on the type(s) of service(s) provided and/or activity(ies) performed. |
| Categorization |
0: In Development |
The grouping of data into meaningful categories based on common attributes or criteria. |
| Census Agglomeration |
1: Draft |
An area formed by one or more adjacent municipalities centred on a population (known as the core). A Census Agglomeration (CA) must have a core population of at least 10,000, based on data from the previous Census of Population Program. To be included in the CA, other adjacent municipalities must have a high degree of integration with the core, as measured by commuting flows derived from data on place of work from the previous Census Program. |
| Census Agricultural Region |
1: Draft |
A geographic area within a province or territory formed for agricultural purposes. |
| Census Consolidated Subdivision |
1: Draft |
A group of adjacent census subdivisions within the same census division. Generally, the smaller, more densely-populated census subdivisions (towns, villages, etc.) are combined with the surrounding, larger, more rural census subdivisions, in order to create a geographic level between the census subdivision and the census division. |
| Census Division |
1: Draft |
The group of neighbouring municipalities joined together for the purposes of regional planning and managing common services (such as police or ambulance services). These groupings are established under laws in effect in certain provinces of Canada. Census division (CD) is the general term for provincially legislated areas (such as county, municipalité régionale de comté and regional district) or their equivalents. In other provinces and the territories where laws do not provide for such areas, Statistics Canada defines equivalent areas for statistical reporting purposes in cooperation with these provinces and territories. Census divisions are intermediate geographic areas between the province/territory level and the municipality (census subdivision). |
| Census Metropolitan Area |
1: Draft |
An area formed by one or more adjacent municipalities centred on a population (known as the core). A Census Metropolitan Area (CMA) must have a total population of at least 100,000, of which 50,000 or more must live in the core, based on adjusted data from the previous Census of Population Program. To be included in the CMA, other adjacent municipalities must have a high degree of integration with the core, as measured by commuting flows derived from data on place of work from the previous Census Program. |
| Census Metropolitan Influenced Zone |
0: In Development |
A concept that geographically characterizes the areas of Canada outside census metropolitan areas (CMAs) and census agglomerations (CAs). Census Subdivisions (CSDs) within provinces that are outside CMAs and CAs are assigned to one of four categories according to the degree of influence (strong, moderate, weak or no influence) that the CMAs or CAs have on them. CSDs within the territories that are outside CAs are assigned to a separate CMIZ category. |
| Census Subdivision |
1: Draft |
The general term for municipalities (as determined by provincial/territorial legislation) or areas treated as municipal equivalents for statistical purposes (e.g. Indian reserves, Indian settlements, and unorganized territories). Municipal status is defined by laws in effect in each province and territory in Canada.
The term "Indian" is used to reflect the language used in legislation, such as the Indian Act, both historically and today. |
| Census Tract |
1: Draft |
A small, relatively stable geographic area that usually has a population of less than 7,500 persons, based on data from the previous Census of Population Program. Census Tracts are located in Census Metropolitan Areas (CMAs) and in Census Agglomerations (CAs) that had a core population of 50,000 or more in the previous census. |
| Classification |
0: In Development |
The process of assigning data to discrete, exhaustive, and mutually exclusive classes based on rules or algorithms.
|
| Clinician |
1: Draft |
A regulated provider who offers preventive, curative, promotional, or rehabilitative health and social services in a systematic way to individuals, families, or communities. |
| Code |
1: Draft |
The unique identifier or expression used to represent a specific coded concept within a code system. Codes serve as concise labels for standardized communication and data exchange. |
| Code System |
1: Draft |
A structured collection of coded concepts, their formal definitions, and their assigned codes. All codes are unique within a code system. Codes within a Code System are mutually exclusive. The structure of a code system can organize concepts in meaningful ways. Examples of a Code System include ICD-10-CA classifications, SNOMED CT, and LOINC. |
| Codeable Concept |
1: Draft |
A concept linked to a value set, where one or more codes from the value set is used to represent the concept. For example, one of the values of the codeable concept of "Allergy or intolerance" may be "91935009", which represents the coded concept "Allergy to peanut" in the SNOMED CT code system. |
| Coded Concept |
1: Draft |
An idea represented by a unique concept identifier (code) within a code system or value set. |
| Cohort |
0: In Development |
A defined collection of individuals who share common characteristics or experience over a specified period. A Cohort is often studied or monitored to identify health events, analyze health outcomes, interventions, or trends. |
| Concentration Strength Quantity |
0: In Development |
The amount of basis of strength substance present per unitary amount (e.g. per mL, per tablet) of the drug product. Concentration Strength Quantity includes both volume and mass. Either presentation strength quantity or concentration strength quantity can be used to describe the product strength. |
| Concept |
1: Draft |
A distinct abstract idea that represents a category of real-world objects, events, places, or people. Examples of clinical concepts include "provider", "immunization", and "encounter". Examples of technical concepts include "metadata", "value set", and "code". |
| Conceptual Data Model |
0: In Development |
A high-level model that highlights the key real-world concepts. This model provides more details than the Information Model, but does not provide the detailed attributions that are in the Logical Data Models. |
| Continuous Episode of Care |
0: In Development |
A contiguous inpatient hospitalization or same-day surgery visit. Defined based on Episode of Care. |
| Country |
1: Draft |
A geographic and/or political region of the world. |
| Data Element |
1: Draft |
A distinct unit of information that represents a specific attribute or characteristic in a data set. Examples include given name, person address type, or birth date. |
| Data Set |
1: Draft |
A collection of data elements organized based on shared characteristics or intended purpose. |
| Death |
0: In Development |
The irreversible cessation of all vital functions of a person. |
| Description |
0: In Development |
A textual representation of a thing. |
| Digital Identity |
0: In Development |
A piece of electronic information that uniquely identifies an individual or organization. A Digital Identity can be stored on digital devices like smartphones and computers. |
| Dimension |
0: In Development |
A parameter according to which data is classified or categorized Defined based on Categorization and Classification. |
| Dissemination Area |
1: Draft |
A small, relatively stable geographic unit composed of one or more adjacent dissemination blocks with an average population of 400 to 700 persons, based on data from the previous Census of Population Program. |
| Dissemination Block |
1: Draft |
An area bounded on all sides by roads and/or boundaries of standard geographic areas. The Dissemination Block is the smallest geographic area for which population and dwelling counts are disseminated. Dissemination blocks cover all the territory of Canada. |
| Document |
0: In Development |
A recorded piece of written, printed, or electronic matter that provides information or evidence. |
| Dose |
1: Draft |
The specific quantity of substance of a drug product administered or prescribed at one time to achieve the desired therapeutic effect. The Dose may vary depending on factors such as the individual's age, weight, and medical condition. |
| Dose Form |
1: Draft |
The physical formulation (e.g., tablet, capsule, solution, cream) of a drug product.
Defined based on Dose. |
| Dose Total Series |
1: Draft |
The recommended number of doses of a vaccine required for immunity. This number may vary based on factors such as age, health conditions, or previous vaccination. Defined based on Immunization and Dose. |
| Drug Code |
0: In Development |
A code that identifies the drug within the context of a drug code system. Defined based on Drug Product. |
| Drug Code System URI |
0: In Development |
The URI of the system that creates and maintains the value set codes. Defined based on Drug Product. |
| Drug Identification Number |
0: In Development |
A computer-generated eight-digit number assigned by Health Canada to a drug product in Canada. A Drug Identification Number uniquely identifies all drug products sold in a dosage form in Canada and is located on the label of prescription and over-the-counter drug products that have been evaluated and authorized for sale in Canada. A DIN uniquely identifies the following product characteristics: manufacturer; product name; active ingredient(s); strength(s) of active ingredient(s); pharmaceutical form; route of administration. |
| Drug in Point-of-Care System |
|
The specific point-of-care drug code system and code. Different providers may be using different code systems (knowledge bases); some of them are proprietary and not accessible for interoperability purposes.
This information will be maintained dynamically by point-of-care systems as it is entered, and not pre-populated with all possible codes. |
| Drug Product |
0: In Development |
A substance or mixture of substances that can impart biological, physiological, or psychological effects by exerting pharmacological, immunological, or metabolic action. Drug Product includes both prescription and non-prescription drugs. They may be administered by a device, but do not include the medical device(s). |
| Drug Product Lot |
0: In Development |
A specific drug product batch that is identifiable by a unique lot number. Drug Product Lot is used to track and recall a drug product if necessary for the quality and efficiency of a particular batch. |
| Drug Status Code |
0: In Development |
A code that indicates the lifecycle state of availability of the drug product in the supply chain. Defined based on Drug Product. |
| Economic Region |
1: Draft |
A grouping of complete census divisions (CDs) created as a standard geographic unit for analysis of regional economic activity. There is one exception in Ontario. |
| Effective Date Time |
1: Draft |
The first date and time by which the information specified is documented. The default value is metadata of when the record was created and requires no human input. |
| Encounter |
1: Draft |
A single interaction with a finite start and end point between one or more patients, either alone or in a group, receiving health service(s) from one or more healthcare providers in a single organization. Encounter includes virtual (i.e. telephone, video conference, secure messaging) and in-person interactions. |
| Entity |
1: Draft |
An encapsulation of data that is recognized by a domain expert as a representation of a discrete concept. An entity includes clinical concepts related to healthcare such as "immunization" as well as supporting concepts such as "metadata", "code", "business glossary". |
| Entity Relationship |
1: Draft |
An association between entities. It may be depicted in a data model by a line with each end showing the cardinality of the related entities, which represents their allowed degrees of interaction (e.g. zero to many). Entity Relationships can represent hierarchies, including parent-children relationships. |
| Episode of Care |
0: In Development |
All healthcare encounters involved in the treatment of a specific problem or set of problems related to a patient's health or healthcare. Transfer of care may be required to shift responsibilities from one organization, care team, or provider to another. Each Episode of Care relates to a specific patient or group of patients. A problem or issue may include multiple health concerns. An episode of care may contain multiple encounters, spanning a long period of time without a finite end date. |
| Ethnicity |
0: In Development |
A multi-dimensional concept referring to community belonging and a shared cultural group membership. It is related to socio-demographic characteristics, including language, religion, geographic origin, nationality, cultural traditions, ancestry and migration history, among others. |
| Event |
0: In Development |
An occurrence that has already taken place, that is currently ongoing, or may take place in the future. Event is a broad definition that encompasses many subtypes of events such as health events, legal events, and environmental events. |
| Evidence |
0: In Development |
A manifestation or a symptom that led to the reporting of a health concern. |
| Excipient |
1: Draft |
An inactive chemical component of a drug product that serves various purposes, such as ensuring stability, aiding in the delivery of the active ingredient, and improving the appearance of the medication. Defined based on Drug Product. An Excipient does not produce health benefits for patients. |
| Expiry Date Time |
1: Draft |
The first date when the information specified is no longer valid. The default value is metadata of when the record is marked as inactive. |
| Family History |
0: In Development |
A collection of health conditions and illnesses that affects or has affected a patient's biological relatives. Family History can help identify genetic risks and predispositions associated with diseases. |
| Federal Election District |
1: Draft |
A geographic area represented by a member of Parliament in the Canadian House of Commons. Each Federal Election District (FED) is part of a single province or territory. |
| Formal |
0: In Development |
Refers to a structured, professional, and official manner of operation that adheres to established rules, protocols, or conventions. Formal operations are typically more rigid and long-lasting in comparison to informal ones. |
| Formal Caregiver |
1: Draft |
A registered individual who offers support, assistance, or care to another individual who may be unable to fully care for themselves due to illness, disability, aging, or other challenges. Examples include personal support workers, volunteers. Formal caregivers are typically registered through a healthcare organization. |
| Forward Sortation Area |
1: Draft |
The geographic area determined by the first three characters of the postal code, designating a postal delivery area within Canada. Each Forward Sortation Area (FSA) is part of a single province or territory. |
| Gender Identity |
2: Proposed |
An individual’s personal experience of being a woman, man, nonbinary or how the person prefers to self-describe. People may identify with more than one gender identity or use different gender identities in different settings |
| Gender Used |
2: Proposed |
The gender that a person wishes to have recorded on legal documents or for the purposes of interactions with official agencies (i.e., Drivers’ License). |
| Geography Boundary |
0: In Development |
The abstract line(s) or physical feature(s) that separate one place or area from another. |
| Health |
1: Draft |
A state of complete physical, mental and social well-being and not merely the absence of disease or infirmity. |
| Health Concern |
0: In Development |
Any health-related condition(s), situation(s), or problems(s) related to a person's health that may be documented in an encounter. Health Concern includes physical (e.g. difficulty breathing) and psychosocial (e.g. Social Determinants of Health) health concern(s). |
| Health Event |
0: In Development |
An occurrence or incident that relates to a person's health, wellbeing, or healthcare. |
| Health Region |
1: Draft |
A geographic area of interest to health authorities, including regions under the jurisdiction or responsibility of provincial and territorial governments or as well as federal, provincial or territorial administrative bodies. Health regions, being provincial administrative areas, are subject to change. For complete Canadian coverage, each of the northern territories as well as the province of Prince Edward Island represents a single health region. |
| Health Service Event |
0: In Development |
An act that is being performed, has been performed, or will be performed by a provider in a formal setting with the intention of directly or indirectly improving the health of the person or populations for whom it is provided. |
| Healthcare Organization |
1: Draft |
A formal group of individuals in an operational structure that delivers healthcare good(s) and service(s). Healthcare Organization includes a wide range of entities, from corporations to community groups. This encompasses public, private, non-profit, and voluntary-sector organizations. |
| Identifier |
1: Draft |
A sequence of characters and/or numbers used to uniquely represent something within a specific context. A code is a unique identifier in a code system. Examples include healthcare identifiers, personal identifiers, and financial identifiers. |
| Immunization |
0: In Development |
The process by which a person develops resistance against a disease through exposure to the immunizing agent. This is often triggered through vaccination. A patient may have an immunization record summarizing all diseases to which they are immune. |
| Immunization Reaction |
0: In Development |
A reaction associated with an Immunization. Defined based on Immunization. |
| Income Decile |
0: In Development |
A distribution measure of the population according to their income, divided into ten equal groups, each representing 10 percent of the population. |
| Income Quintile |
0: In Development |
A distribution measure of the population according to their income, divided into five equal groups, each representing 20 percent of the population. |
| Indigenous Self-identification |
2: Proposed |
The person's self-identification as First Nations, Inuk/Inuit and/or Métis |
| Informal |
0: In Development |
Refers to a casual or less structured style of operation, often in a non-professional setting. Informal operations are typically more flexible and temporary in comparison to formal ones. |
| Informal Caregiver |
1: Draft |
An unregistered individual who offers support, assistance, or care to another individual who may be unable to fully care for themselves due to illness, disability, aging, or other challenges. Examples include family members, friends, and neighbours. |
| Information Model |
0: In Development |
A high-level model that highlights the key real-world concepts important to understand a person's health and how they relate. |
| Intervention |
1: Draft |
An action or series of actions performed for, with or on behalf of a person or population whose purpose is to observe, monitor, assess, improve, maintain, promote, or modify health, functioning or health conditions. Examples include a education program, an operation, and a community health initiative. |
| Latitude |
0: In Development |
The location of a point on the earth's surface, stated as an angular measurement in degrees, minutes, and seconds north or south of the equator. |
| Local Delivery Unit |
0: In Development |
The last three characters of a Canadian postal code (numeric-alpha-numeric). This identifies the smallest delivery unit in an FSA. Local Delivery Unit is the last three characters of a postal code. |
| Location (Geographical) |
1: Draft |
A specific geographic position or site. |
| Location Purpose |
0: In Development |
The rationale for providing information about the physical geographical coordinates of where a Party resides. Examples include business location, mailing location, and billing location. |
| Logical Data Model |
0: In Development |
A semantically rich, fully attributed model that organizes and standardizes health data concepts and how they relate to each other and to the real world. This model is integrated with the Pan-Canadian Health Data Content Standard and will be a foundational component for data management and data exchange. |
| Longitude |
0: In Development |
The location of a point on the earth's surface, stated as an angular measurement in degrees, minutes, and seconds east or west of the Greenwich prime meridian. |
| Lot Number |
0: In Development |
A unique combination of letters, figures, or both assigned to a specific group of drug products at the time of production which can be used to track its manufacturing, processing, packaging, holding, and distributing history. Defined based on Drug Product Lot. |
| Manufactured Drug Product |
1: Draft |
A brand-specific drug that is or, within the lifetime of the Canadian Clinical Drug Data Set (CCDD), has been available for prescribing and dispensing in Canada. An example includes ACT AMLODIPINE (amlodipine (amlodipine besylate) 2.5 mg oral tablets) ACTAVIS PHARMA COMPANY. |
| Medical Device |
1: Draft |
A manufactured instrument, apparatus, machine, software, implant, or similar item that is intended for use in the monitoring, diagnosis, prevention, mitigation, or alleviation of a condition or injury. |
| Medication Administration |
1: Draft |
The process by which medication is given to a patient. Information regarding the route of administration, dose, and schedule may be documented. |
| Medication Dispensation |
1: Draft |
The preparation and fulfillment of a medication order by a pharmacist or authorized clinician. The dispensing provider(s) will review the pharmaceutical and therapeutic suitability of the medication and explain the administration instruction to the patient. |
| Medication Incident |
1: Draft |
A preventable event that may cause or lead to patient harm while the medication is under the control of the healthcare provider, patient, or consumer. Examples include errors of administration and omission. |
| Medication Request |
1: Draft |
An order for medication by a clinician. An order typically includes the medication name, number of refills, and frequency. |
| Medication Statement |
1: Draft |
A summary record of all the medication(s) a patient has taken, is taking, or could be taking. Medication Statement includes any medication that could induce drug interactions or have an impact on patient health such as prescription medications, non-prescription medications, and natural health products. |
| Name |
1: Draft |
A word or combination of words by which a person, place, or thing is referred to. Examples include Party Group name, Organization name, and Person name. |
| Non-proprietary Therapeutic Drug Product |
1: Draft |
A brand-independent and clinically-oriented representation of a manufactured (therapeutic) product. A Non-proprietary Therapeutic Drug Product is characterized by the strength of its active ingredient(s), the dosage form, and unit of presentation. An example includes amlodipine (amlodipine besylate) 2.5 mg oral tablet. |
| Organization |
0: In Development |
A formal collection of individuals in an operational structure formed to achieve a common purpose. Organization includes a wide range of entities, from corporations to community groups. Organizations may encompass public, private, non-profit and voluntary- sector organizations. |
| Participant |
0: In Development |
A person who is taking part, has been taking part, or will take part in a particular event. |
| Party |
0: In Development |
An individual or group of individuals with defined roles and common properties.
An Organization is considered a Party. |
| Party Group |
0: In Development |
A collective of individuals, organizations, or other party groups with shared characteristic(s) or purpose(s). Party Group includes both self-identified groups such as families and groups organized for analytical purposes such as cohorts (ex. diabetes management cohort). |
| Party Group Criteria Text |
0: In Development |
The condition(s) used to define a Party Group. Defined based on Party Group. Examples include demographic information (e.g. age), geographic location, or organizational role. |
| Party Group Member |
0: In Development |
An individual or organization in a specific Party Role, recognized as belonging to a Party Group at a given time. Certain Party Groups such as Virtual Health Networks have defined members, whereas other groups such as Cohorts do not. A Party (e.g. one person) can be member of a Party Group (e.g. Hospital Organization) in one or more of its roles (e.g. Patient or Provider). |
| Party Group Name |
0: In Development |
The name by which a Party Group is known to its members and to parties that interact with it. Defined based on Party Group and Name. Examples include Alcoholics Anonymous, Mississauga Cancer Survivors Support Group, and Groupe de prévention de suicide de Rimouski. |
| Party Group Purpose Text |
0: In Development |
The rationale for the formation of a specific Party Group. Examples include studying the effectiveness of heart disease treatment (Cohort purpose), alcohol recovery (Peer Support Group purpose), and health service proximity (Virtual Health Network purpose). |
| Party Group Type |
0: In Development |
A code that designates the class of a Party Group. Defined based on Party Group and Classification. |
| Party Location |
0: In Development |
A specific geographically determined locale of a Party (individual, organization, or group). Defined based on Party. |
| Party Role |
0: In Development |
A Party fulfilling a specific function related to the Canadian healthcare system. |
| Party Role Relationship |
0: In Development |
A pair of associated Party Roles related to the Canadian healthcare system. |
| Party Role Relationship Type |
0: In Development |
A class of relationships that a Party Role can participate in. Examples include "is sister of", "is managed by", or "employee of".
Defined based on Party Group and Classification. |
| Party Role Type |
0: In Development |
A class of roles that Parties can fulfill. Examples of Person Role Type are patient, provider, etc. Examples of Organization Role Type are Primary Care Organization, Identifier Issuing Organization, etc.
Defined based on Party Group and Classification. |
| Party Service Language |
0: In Development |
The preferred language of service for an individual, a group of individuals, or an organization. |
| Party Type |
0: In Development |
A class of Party as a Person, Organization, or Party Group. |
| Patient |
1: Draft |
A person who has received, currently receives, or is waiting to receive healthcare goods and services from a provider or organization. Patients can be co-producers of their health and are active participants in their care. Depending on the health setting or context, patients may be referred to as clients, residents, or community members. |
| Patient Encounter |
0: In Development |
An encounter for one patient, either alone or in a group, to receive health service(s) from one or more healthcare providers. Defined based on Encounter. Patient Encounter is an Encounter applied to a singular patient. During a group encounter (e.g. couples therapy session), a separate patient encounter is made for each individual. |
| Patient Medical History |
0: In Development |
A collection of health and social factors that affects or has affected a patient. Patient Medical History includes clinical findings, surgical history, family history, and genetic information. It also emphasizes protective factors such as exercise routines and overall sense of mental and physical well-being. |
| Patient Summary |
1: Draft |
A standardized set of basic clinical data that includes the most important health and care related facts required to ensure safe and secure healthcare. This summarized version of the patient’s clinical data gives health professionals the essential information they need to provide care in the case of an unexpected or unscheduled medical situation (e. g. emergency or accident). |
| Peer Support Group |
0: In Development |
A collection of individuals who share a common experience, condition, or challenge, and come together to provide mutual support, encouragement, and understanding to one another. |
| Person |
1: Draft |
An individual human. Demographic, administrative, and/or health information about a person may be collected and maintained. A person may be in the role of a patient, caregiver, provider, or a relative of a patient. |
| Person Information |
0: In Development |
The identifying, administrative, and demographic information of an individual. Person Information includes name, sex at birth, contact information, and address. |
| Precise Active Ingredient Substance Description |
0: In Development |
A set of precise active ingredient substance(s) that provides the therapeutic effect of the drug product and which are described using the fullest and most specific description of the substance as it is used in the product(s) that the concept represents. The Precise Active Ingredient Substance may include various modifiers, such as salts, esters and/or polymers (e.g. pegylation); not all substances, even when used as the precise active ingredient substance, have a modification. Examples include phenytoin sodium (in Pfizer’s Dilantin capsule), and sumatriptan succinate (in GSK’s Imitrex DF tablet). |
| Presentation Strength Quantity |
0: In Development |
The amount of the basis of strength substance present in the unit of presentation (e.g. syringe, vial) of or in the total volume of the drug product. Presentation Strength Quantity includes volume or mass. Either presentation strength quantity or concentration strength quantity can be used to describe the product strength. |
| Procedure |
1: Draft |
An action ordered by, or carried out by, one or more healthcare provider(s) on the patient for therapeutic or diagnostic, or other healthcare purposes such as assessment, counseling, vaccination purposes. Procedure includes psychological and medical therapies. Examples include a colonoscopy, an appendectomy, and knee replacement surgery. |
| Product |
1: Draft |
A tangible good, intangible service, or any combination thereof. This may include health products, digital products, or commercial products. |
| Protocol |
1: Draft |
A set of guidelines and standards on how particular processes and actions should be carried out. Clinical protocols are typically informed by a systematic review of evidence and include recommendations to optimize healthcare. |
| Provider |
1: Draft |
An individual who has delivered, is delivering, or has the potential to deliver health care-related good(s) and service(s). This includes Clinicians, Allied Health Professionals, Personal Support Workers, Volunteers, Elders, and Knowledge Keepers. |
| Province or Territory |
1: Draft |
The name associated with geographic boundaries in Canada, as well as the major political units of Canada. |
| Pseudo Drug Identification Number |
0: In Development |
An eight-digit number assigned by a drug program in cases where a benefit has not been assigned a DIN by Health Canada. This is to typically identify non-drug benefits (e.g., diabetic supplies) and is sometimes used to differentiate benefits based on package size or covered indication (e.g., methadone for addiction versus pain control). |
| Public Health Event |
0: In Development |
Any event that represents an immediate threat to human health and requires prompt action, i.e. the implementation of control and/or mitigation measures to protect the health of the public. |
| Racialized Group |
0: In Development |
A social construct used to judge and categorize people based on perceived differences in physical appearance in ways that create and maintain power differentials within social hierarchies. There is no scientifically supported biological basis for discrete racial groups. |
| Reaction Manifestation |
0: In Development |
A symptom or sign associated with an allergy or intolerance reaction. |
| Recorded Sex or Gender |
2: Proposed |
The documented sex or gender of an individual used for clinical, official, or legal purposes where only one data field for sex and gender is available, and where it is the value found in the local system and/or historical documentation. |
| Regulated |
1: Draft |
To be governed or controlled by provincial, territorial, and sometimes federal law. Governments may designate a professional or regulatory body to monitor the membership and scope of practice for a regulated occupation. Through these laws, regulated occupations are granted the ability to perform controlled acts such as prescription and surgery. |
| Related Health Concern |
0: In Development |
A health concern associated with some other health concern of interest for the same patient. |
| Service Language Code |
0: In Development |
The code designated to the person's language of service. Defined based on Party Service Language. |
| Sex Parameter for Clinical Use |
2: Proposed |
A parameter that provides guidance on how a recipient should apply settings or reference ranges that are derived from observable information such as an organ inventory, recent hormone lab tests, genetic testing, menstrual status or obstetric history. This property is intended for use in clinical decision making and indicates that treatment or diagnostic tests should consider best practices associated with the relevant reference population. |
| Sexual Orientation |
2: Proposed |
How a person describes their sexuality or who a person is romantically or physically attracted to. |
| Social Determinants of Health |
0: In Development |
The non-medical factors that influence health outcomes. They are the conditions in which people are born, grow, work, live, and age, and the wider set of forces and systems shaping the conditions of daily life. Social Determinants of Health forces and systems include economic policies and systems, development agendas, social norms, social policies and political systems. |
| Social History |
1: Draft |
Aspects of an individual's personal life and social behaviour that may impact their health. Social History includes current and historical occupational information, recreational behaviour, and relationship status as well as spiritual values. |
| Statistical Area Classification |
1: Draft |
The grouping of census subdivisions (CSD) according to whether they are a component of a census metropolitan area (CMA), a census agglomeration (CA) or a census metropolitan influenced zone (MIZ). CSDs within provinces that are outside CMAs and CAs are assigned to one of four categories according to the degree of influence (strong, moderate, weak or no influence) that the CMAs or CAs have on them. CSDs within the territories that are outside CAs are assigned to a separate category.
The SAC is a variant of the Standard Geographical Classification (SGC). CSDs form the lowest level of the classification variant. The next level consists of CMAs, CAs and MIZs including the territories. The highest level consists of two categories that cover all of the land mass of Canada:
-inside census metropolitan areas and census agglomerations
-outside census metropolitan areas and census agglomerations |
| Street Direction |
0: In Development |
Information on the cardinal direction of a street. Examples include North, North West, E, and SW. |
| Street Name |
0: In Development |
The official label that identifies a street. |
| Street Number |
0: In Development |
The number of a property on a street that an address identifies. |
| Street Number Suffix |
0: In Development |
A suffix added to Street Number to provide unique localization. Examples include "1/4", "A", and "B". |
| Street Type |
0: In Development |
A suffix that identifies information of the street. Examples include highway, street, and avenue. |
| Substance Strength |
1: Draft |
The concentration or potency of the active ingredient(s) in a drug product. Drug strength indicates the amount of active ingredients present in a specific unit or volume of the medication. |
| Substance Strength Set |
0: In Development |
The set of active ingredient substance(s), when combined with an expression of their strength. Combination Non-proprietary Therapeutic Drug Products+J106 will have more than one Substance Strength Sets. |
| Suite Number |
0: In Development |
A unique number identifying a room within a building. |
| Suite Type |
0: In Development |
A suffix that identifies the type of room with a defined suite number. Examples include Apartment, Unit, Suite. |
| Term |
0: In Development |
Represents a concept identified by the term name. |
| Therapeutic Moiety |
1: Draft |
The functional and clinically significant part of the active ingredient substance(s) present in a drug product. The Therapeutic Moiety is an abstract representation of a drug product without reference to strength and dose form, focusing only on active ingredient(s). For example, amlodipine. |
| Unit of Presentation |
1: Draft |
The countable entity in which the clinical drug is presented, or by which it is bounded. The Unit of Presentation is used to support the expression of strength and to differentiate between drug products. |
| Vaccination |
0: In Development |
A procedure in which a vaccine containing immunizing agent(s) is introduced into the body in order to stimulate the body's immune response. |
| Vaccine Preventable Disease |
1: Draft |
A disease caused by infectious agent for which a vaccine exists to protect against. |
| Value |
0: In Development |
The numeric and/or alphanumeric character(s) assigned to represent a specific quantity, item, person, or organization. Examples include Organization identifier value, height in centimeters, and phone number. |
| Value Set |
1: Draft |
The finite set of permitted values (codes), drawn from one or more code systems, for a data element representing a codeable concept. A Value Set may include related attributes such as value source, code name, and code description. |
| Virtual Care Network |
0: In Development |
A collection of healthcare providers and/or organizations grouped by shared characteristics such as geography or specialty. |
.jpeg)